| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
Revenues | ||||||
Sales commission and other | ||||||
465 | 414 | 297 | ||||
License fees (note 5) | ||||||
458 | 497 | 248 | ||||
Total revenues | ||||||
923 | 911 | 545 | ||||
Operating expenses (note 17) | ||||||
Research and development costs | ||||||
10,704 | 16,495 | 17,234 | ||||
General and administrative expenses | ||||||
8,198 | 7,147 | 11,308 | ||||
Selling expenses | ||||||
5,095 | 6,745 | 6,887 | ||||
Total operating expenses | ||||||
23,997 | 30,387 | 35,429 | ||||
Loss from operations | ||||||
-23,074 | -29,476 | -34,884 | ||||
Gain (loss) due to changes in foreign currency exchange rates | ||||||
502 | -70 | -1,767 | ||||
Change in fair value of warrant liability (note 14) | ||||||
2,222 | 4,437 | -10,956 | ||||
Warrant exercise inducement fee (note 14) | ||||||
0 | 0 | 2,926 | ||||
Other finance income | ||||||
75 | 150 | 305 | ||||
Net finance income (costs) | ||||||
2,799 | 4,517 | -15,344 | ||||
Loss before income taxes | ||||||
-20,275 | -24,959 | -50,228 | ||||
Income tax recovery (note 20) | ||||||
-3,479 | 0 | 0 | ||||
Net loss from continuing operations | ||||||
-16,796 | -24,959 | -50,228 | ||||
Net income from discontinued operations | ||||||
0 | 0 | 85 | ||||
Net loss | ||||||
-16,796 | -24,959 | -50,143 | ||||
Other comprehensive income (loss): | ||||||
Items that may be reclassified subsequently to profit or loss: | ||||||
Foreign currency translation adjustments | ||||||
-1,430 | 569 | 1,509 | ||||
Items that will not be reclassified to profit or loss: | ||||||
Actuarial gain (loss) on defined benefit plans (note 18) | ||||||
694 | -1,479 | 844 | ||||
Comprehensive loss | ||||||
-17,532 | -25,869 | -47,790 | ||||
Net loss per share (basic and diluted) from continuing operations (in dollars per share) | ||||||
-1.12 | -2,410.00 | -18,170.00 | ||||
Net income per share (basic and diluted) from discontinued operations (in dollars per share) | ||||||
0.00 | 0.00 | 30.00 | ||||
Net loss per share (basic and diluted) (in dollars per share) | ||||||
-1.12 | -2,410.00 | -18,140.00 | ||||
Weighted average number of shares outstanding (notes 24): | ||||||
Basic and diluted (in shares) | ||||||
14,958 | 10,348 | 2,763 | ||||